{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:14:07Z","timestamp":1791252847942,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1053\/j.semnuclmed.2009.11.001","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T04:27:36Z","timestamp":1264825656000},"page":"105-121","source":"Crossref","is-referenced-by-count":157,"title":["Radioembolization of Liver Tumors With Yttrium-90 Microspheres"],"prefix":"10.1053","volume":"40","author":[{"given":"Hojjat","family":"Ahmadzadehfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Ezziddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2009.11.001_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000658-200210000-00001","article-title":"Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade","volume":"236","author":"Jarnagin","year":"2002","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/cncr.24224","article-title":"Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres","volume":"115","author":"Mulcahy","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/030089160409000116","article-title":"Radiotherapy of liver malignancies","volume":"90","author":"Greco","year":"2004","journal-title":"Tumori"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2009.11.001_bib8","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1148\/rg.25si055515","article-title":"Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications","volume":"25","author":"Murthy","year":"2005","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1088\/0031-9155\/45\/4\/316","article-title":"Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy","volume":"45","author":"Campbell","year":"2000","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib10","first-page":"334","article-title":"The blood supply of experimental liver metastases","volume":"68","author":"Lien","year":"1970","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1118\/1.1781332","article-title":"Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma","volume":"31","author":"Sarfaraz","year":"2004","journal-title":"Med Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1118\/1.1538235","article-title":"Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors","volume":"30","author":"Sarfaraz","year":"2003","journal-title":"Med Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib14","first-page":"1673","article-title":"Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres","volume":"41","author":"Dancey","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib15","first-page":"333","article-title":"Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases","volume":"48","author":"Stubbs","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000123319.20705.92","article-title":"Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis","volume":"15","author":"Salem","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","article-title":"90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging","volume":"16","author":"Lewandowski","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","article-title":"Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival","volume":"16","author":"Salem","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib20","first-page":"1196","article-title":"Staging recurrent metastatic colorectal carcinoma with PET","volume":"38","author":"Delbeke","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejso.2003.10.023","article-title":"FDG-PET for the pre-operative evaluation of colorectal liver metastases","volume":"30","author":"Arulampalam","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00432-003-0527-6","article-title":"Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors","volume":"130","author":"Bohm","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02303744","article-title":"Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography","volume":"4","author":"Ogunbiyi","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.crad.2008.08.008","article-title":"Established, emerging and future roles of PET\/CT in the management of colorectal cancer","volume":"64","author":"Herbertson","year":"2009","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006-2007","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jmri.10265","article-title":"Comparison of MR and PET imaging for the evaluation of liver metastases","volume":"17","author":"Yang","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib27","series-title":"Liver Radioembolization with 90Y Microspheres","first-page":"93","article-title":"Radiological detection and assessment of tumor response","author":"Jakobs","year":"2008"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11307-008-0169-9","article-title":"Metabolic tumor width parameters as determined on PET\/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus","volume":"11","author":"Roedl","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","article-title":"Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers","volume":"296","author":"Ramirez de Molina","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib30","first-page":"990","article-title":"PET imaging of prostate cancer using carbon-11-choline","volume":"39","author":"Hara","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.semnuclmed.2007.07.003","article-title":"Cancer imaging with fluorine-18-labeled choline derivatives","volume":"37","author":"Kwee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00259-006-0164-9","article-title":"PET\/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: Preliminary comparison with [(18)F]FDG PET\/CT","volume":"33","author":"Talbot","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2967\/jnumed.108.052639","article-title":"Detection of hepatocellular carcinoma using 11C-choline PET: Comparison with 18F-FDG PET","volume":"49","author":"Yamamoto","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1148\/radiol.2242011283","article-title":"Variant hepatic arterial anatomy revisited: Digital subtraction angiography performed in 600 patients","volume":"224","author":"Covey","year":"2002","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","article-title":"Angiographic considerations in patients undergoing liver-directed therapy","volume":"16","author":"Liu","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0360-3016(95)00039-3","article-title":"Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors","volume":"33","author":"Leung","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: Angiographic and technical considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib38","first-page":"1662","article-title":"The significance of Tc-99m-MAA SPECT-CT liver perfusion imaging in treatment planning for yttrium 90 microsphere selective internal radiation treatment","volume":"50","author":"Ahmadzadehfar","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","article-title":"Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres","volume":"40","author":"Lau","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib40","unstructured":"TheraSphere Yttrium-90 Glass Microspheres Users Manual. MDS Nordion, Ottawa, Ontario, Canada"},{"issue":"suppl 2","key":"10.1053\/j.semnuclmed.2009.11.001_bib41","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.ijrobp.2006.02.061","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: A review","volume":"66","author":"Salem","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2967\/jnumed.108.058347","article-title":"SPECT\/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer","volume":"50","author":"Hamami","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jso.1162","article-title":"Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume","volume":"78","author":"Moroz","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-2006-939842","article-title":"Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver","volume":"23","author":"Lewandowski","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib46","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2349\/biij.2.3.e43","article-title":"Trans-arterial hepatic radioembolisation of yttrium-90 microspheres","volume":"2","author":"Murthy","year":"2006","journal-title":"Biomed Imaging Interv J"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","article-title":"Complications following radioembolization with yttrium-90 microspheres: A comprehensive literature review","volume":"20","author":"Riaz","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/cbr.2008.0543","article-title":"Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry","volume":"24","author":"Fabbri","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib49","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1088\/0031-9155\/53\/20\/008","article-title":"Evaluation of quantitative (90)Y SPECT based on experimental phantom studies","volume":"53","author":"Minarik","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jvir.2007.02.002","article-title":"Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy","volume":"18","author":"Murthy","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib51","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1572-0241.2007.01172.x","article-title":"Gastroduodenal injury after radioembolization of hepatic tumors","volume":"102","author":"Carretero","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","article-title":"Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution","volume":"31","author":"Salem","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib53","first-page":"70","article-title":"Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin","volume":"35","author":"Leung","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1440-1746.2003.03322.x","article-title":"Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer","volume":"19","author":"Yip","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00330-008-1211-7","article-title":"Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: A structured meta-analysis","volume":"19","author":"Vente","year":"2009","journal-title":"Eur Radiol"},{"issue":"2 Pt. 1","key":"10.1053\/j.semnuclmed.2009.11.001_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.RVI.00001142592.89564.F9","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib57","first-page":"200","article-title":"Radiation hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0360-3016(91)90797-8","article-title":"Dose distribution following selective internal radiation therapy","volume":"21","author":"Fox","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib59","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2006.05.065","article-title":"Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma","volume":"66","author":"Sangro","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/07357900802620893","article-title":"A first report of radioembolization for hepatic metastases from ocular melanoma","volume":"27","author":"Kennedy","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jvir.2007.07.016","article-title":"Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma","volume":"18","author":"Young","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiographics.20.2.g00mc33533","article-title":"The AAPM\/RSNA physics tutorial for residents: Internal radiation dosimetry: Principles and applications","volume":"20","author":"Toohey","year":"2000","journal-title":"Radiographics"},{"issue":"2 Pt. 1","key":"10.1053\/j.semnuclmed.2009.11.001_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A risk-stratification analysis","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib64","series-title":"Liver Radioembolization with 90Y Microspheres","first-page":"139","article-title":"Complications and side effects","author":"Hoffmann","year":"2008"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib65","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ijrobp.2008.10.005","article-title":"Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors","volume":"74","author":"Kennedy","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib66","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3748\/wjg.v13.i29.3918","article-title":"Veno occlusive disease: Update on clinical management","volume":"13","author":"Senzolo","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib67","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3748\/wjg.v13.i13.1912","article-title":"Hepatic venous outflow obstruction: Three similar syndromes","volume":"13","author":"Bayraktar","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib69","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jvir.2008.01.003","article-title":"Biliary sequelae following radioembolization with Yttrium-90 microspheres","volume":"19","author":"Atassi","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MNM.0b013e3280121a8f","article-title":"Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres","volume":"28","author":"Szyszko","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib71","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jvir.2007.06.028","article-title":"A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion\/MR imaging monitoring","volume":"18","author":"Lewandowski","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib72","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.acra.2004.09.004","article-title":"Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography","volume":"11","author":"Tran","year":"2004","journal-title":"Acad Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib75","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2006.01.026","article-title":"RECIST revisited: A review of validation studies on tumour assessment","volume":"42","author":"Therasse","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib76","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation","volume":"11","author":"Wahl","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0009-9260(02)00577-9","article-title":"Tumour size measurement in an oncology clinical trial: Comparison between off-site and on-site measurements","volume":"58","author":"Belton","year":"2003","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiology.187.1.8451398","article-title":"Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings","volume":"187","author":"Marn","year":"1993","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1463-1318.2004.00592.x","article-title":"The role of positron emission tomography in the management of colorectal cancer","volume":"6","author":"Tutt","year":"2004","journal-title":"Colorectal Dis"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00259-004-1710-y","article-title":"Sequential FDG PET\/CT in 90Y microsphere treatment of unresectable colorectal liver metastases","volume":"32","author":"Bienert","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib81","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00259-004-1752-1","article-title":"90Y microsphere treatment of unresectable liver metastases: Changes in 18F-FDG uptake and tumour size on PET\/CT","volume":"32","author":"Bienert","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib82","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.sla.0000146145.69835.c5","article-title":"Does the novel PET\/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?","volume":"240","author":"Selzner","year":"2004","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib83","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00259-002-0787-4","article-title":"Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: A comparison with CT or MRI","volume":"29","author":"Wong","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib84","first-page":"1892","article-title":"Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: Comparison of quantitative and visual analyses by 18F-FDG PET","volume":"45","author":"Wong","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.108.056408","article-title":"The effectiveness of 18F-FDG PET\/CT combined with STIR MRI for diagnosing nodal involvement in the thorax","volume":"50","author":"Morikawa","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib86","first-page":"249","article-title":"Treatment of colorectal liver metastases with SIR-Spheres plus chemotherapy","volume":"3","author":"Gray","year":"2000","journal-title":"GI Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib87","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib88","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1445-2197.2006.03834.x","article-title":"Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: Single-centre experience with 100 patients","volume":"76","author":"Stubbs","year":"2006","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib89","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomised phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"Van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2472062029","article-title":"Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres\u2014Safety, efficacy, and survival","volume":"247","author":"Sato","year":"2008","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib91","doi-asserted-by":"crossref","unstructured":"Cosimelli M, Mancini R, Carpanese L, et al: Clinical safety and efficacy of 90yttrium resin microspheres alone in unresectable, heavily pre-treated colorectal liver metastases: Results of a phase II trial. In: Proceedings from the ASCO Annual Meeting; 2008; Chicago, IL","DOI":"10.1200\/jco.2008.26.15_suppl.4078"},{"issue":"6A","key":"10.1053\/j.semnuclmed.2009.11.001_bib92","first-page":"711","article-title":"A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: Preliminary results on toxicity and response rates","volume":"20","author":"Mancini","year":"2006","journal-title":"In Vivo"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib93","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2006.08.7916","article-title":"Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy","volume":"25","author":"Sharma","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib94","unstructured":"Van Hazel G, Pavlakis N, Goldstein D: Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study. In: Proceedings from the ASCO Annual Meeting. ASCO GI Symposium, Hollywood, FL; 2005 (abstract 265)"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib95","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1200\/JCO.2005.05.2118","article-title":"Portal hypertension and liver surgery following selective internal radiation therapy with 90Yttrium microspheres","volume":"24","author":"Stubbs","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib96","first-page":"311","article-title":"Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors","volume":"53","author":"Riaz","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"5 suppl 1","key":"10.1053\/j.semnuclmed.2009.11.001_bib97","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma","volume":"127","author":"Geschwind","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib98","doi-asserted-by":"crossref","unstructured":"Salem R, Lewandowski RJ, Mulcahy MF, et al: Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes. Gastroenterology (in press)","DOI":"10.1053\/j.gastro.2009.09.006"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib99","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1096-9098(200005)74:1<24::AID-JSO6>3.0.CO;2-V","article-title":"Result of liver resection as treatment for metastases from noncolorectal cancer","volume":"74","author":"Benevento","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib101","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0b013e3181728a45","article-title":"90Y Radioembolization for metastatic neuroendocrine liver tumors: Preliminary results from a multi-institutional experience","volume":"247","author":"Rhee","year":"2008","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib102","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","article-title":"Radioembolization for unresectable neuroendocrine hepatic metastases using resin Y-90-microspheres: Early results in 148 patients","volume":"31","author":"Kennedy","year":"2008","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib103","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cncr.23685","article-title":"Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases","volume":"113","author":"King","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000209849","article-title":"Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: A prospective single center study","volume":"79","author":"Kalinowski","year":"2009","journal-title":"Digestion"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jvir.2008.01.009","article-title":"Radioembolization in patients with hepatic metastases from breast cancer","volume":"19","author":"Jakobs","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib106","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2007.03.056","article-title":"Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer","volume":"69","author":"Coldwell","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib107","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","article-title":"Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: Results from a pilot study","volume":"113","author":"Ibrahim","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2009.11.001_bib108","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/bjc.1973.40","article-title":"An autopsy study of some routes of dissemination of cancer of the breast","volume":"27","author":"Viadana","year":"1973","journal-title":"Br J Cancer"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299809001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299809001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T09:28:04Z","timestamp":1558776484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299809001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0001299809001056"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2009.11.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}